Amniotic mesenchymal stem cells have robust angiogenic properties and are effective in treating hindlimb ischaemia

Abstract

AMMs are not only markedly angiogenic but also vasculogenic, thus ameliorating hindlimb ischaemia. Our data suggest that AMMs have considerable therapeutic effects on ischaemic hindlimb through high angiogenic and engraftment abilities.